1154740-46-1

Basic information

• Product Name: 2-amino-4-bromo-3-methylphenol
• Synonyms: 2-amino-4-bromo-3-methylphenol
• CAS NO: 1154740-46-1
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 1154740-46-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-amino-4-bromo-3-methylphenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-4-bromo-3-methylphenol(1154740-46-1)
• EPA Substance Registry System: 2-amino-4-bromo-3-methylphenol(1154740-46-1)

Safety Data

• Hazardous Substances Data: 1154740-46-1(Hazardous Substances Data)

Usage

Also Known As

Ethyl p-aminobenzoate

Use in Synthesis

Commonly used in the synthesis of pharmaceuticals and dyes

Applications

Used in the production of hair dyes and cosmetics

Physical State

White to off-white crystalline powder

Solubility

Soluble in ethanol and ether, slightly soluble in water

Handling Precautions

Requires careful handling due to potential skin and eye irritation

Health Risks

May be harmful if swallowed or inhaled

Safety Measures

Use of protective gear and proper ventilation recommended for safe handling

Upstream product

• 4920-77-8 3-methyl-2-nitrophenol 
• 85598-12-5 4-bromo-3-methyl-2-nitro-phenol 

Downstream Products

• 1154740-48-3 6-bromo-5-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine 
• 1154740-49-4 5-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine 

Relevant articles and documents

Novel benzoxazolone compound

PROBLEM TO BE SOLVED: To provide a therapeutic agent for diseases such as neuropathic pain, nociceptive pain, inflammatory pain, small diameter fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria or multiple sclerosis. SOLUTION: There is provided a benzoxazolone compound represented by the formula (1) or a pharmaceutically acceptable salt. (1), where R1 and R2 are each independently H or C1-6 alkyl, where the alkyl may be substituted by hydroxy, C1-4 alkylsulfonyl, aminocarbonyl or 4 to 7-membered heterocycloalkyl, or the like, L is C1-6 alkylene, R3 is C1-6 alkyl, C3-7 cycloalkyl, where the cycloalkyl may be substituted by halogen or hydroxy or the like, C6-10 aryl, where the aryl may be substituted by halogen, C1-4 alkyl or C1-4 haloalkyl or the like, R4 is H, halogen or C1-4 alkyl. SELECTED DRAWING: None COPYRIGHT: (C)2017,JPOandINPIT

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The present invention relates to compounds of formula (I) wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection